Skip to content

Monofocal Extended Range of Vision (MERoV) Study

Monofocal Extended Range of Vision (MERoV) Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04011696
Acronym
MERoV
Enrollment
412
Registered
2019-07-08
Start date
2019-07-03
Completion date
2022-05-31
Last updated
2023-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aberration, Corneal Wavefront, Accomodation, Pseudophakia

Keywords

pseudoaccommodation, monofocal IOL, cataract surgery

Brief summary

The investigators are proposing this research project to: 1. Screen a set of patients after normal cataract surgery with a single focus lens aimed at good distance vision at 3 months after surgery to identify patients who are able to see and read well without glasses. 2. Identify the combination of factors responsible for this phenomenon in the patients who are achieving this. Potentially eligible patients will be given an invitation letter and patient information sheet on the day they arrive for surgery. They will then be asked if they are happy to be contacted by phone 2-4 weeks post-surgery with a view to booking them into an additional research visit at 3 months after their surgery. At 3 months after surgery they will have their un-corrected vision checked. They will also have their reading speed assessed without any glasses. They will undergo a through refractive check by an optometrist to assess the power of the spectacles (if needed) and following this they will have a scan of the eye (a technique known as wave front analysis which uses very sophisticated optics) to capture the optical distortions in the structures of the eye. If this study is able identify factor/s responsible for giving good unaided reading and distance vision then this factor can be reproduced in eyes undergoing cataract surgery. This will mean that the patients can have an increased option of spectacle independence without the need for expensive multifocal IOLs and their associated side effects such as glare and halos, particularly at night.

Detailed description

TYPE OF THE STUDY: A prospective, non-blinded, non-randomized, single eye cohort study in patients who had uneventful cataract surgery with a monofocal IOL. Potentially eligible patients will be given an invitation letter and patient information sheet on the day they arrive for surgery. They will then be asked if they are happy to be contacted by phone 2-4 weeks post-surgery with a view to booking them into an additional research visit at 3 months after their surgery. Inclusion criteria 1. Uneventful cataract surgery 2. Sequential recruitment 3. Potential to see 20/40 (6/12) unaided or better postoperatively 4. No significant macular pathology 5. Willing to follow up at 3 months Exclusion criteria 1. Patients under 20 years of age 2. Any ocular co-morbidity, which will preclude an expected postoperative 20/40 (6/12) unaided, distance vision. (e.g. amblyopia, corneal pathology, age related macular degeneration, glaucoma, diabetic retinopathy, other previous ocular surgeries) 3. Posterior capsule opacification 4. Inability to read English text or physically or mentally unable to cooperate with the postoperative assessment At 3 months, uniocular unaided distance LogMAR acuity will be recorded. An OCT scan will be performed to establish macular integrity. Pupil size, manifest refraction, measurement of any deviations of the optical rays (called as wavefront aberrometry) will be performed using a iTrace (Tracy Technology) wavefront aberrometer. Unaided reading speed and critical print size will be measured using a Salzberg Reading Desk. Examination time per patient: 40 mins in total. Multivariate statistical analysis will be performed. Power calculation showed a need to examine 412 patients.

Interventions

None listed

Sponsors

King's College London
CollaboratorOTHER
European Society of Cataract and Refractive Surgeons
CollaboratorOTHER
Brighton and Sussex University Hospitals NHS Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Uneventful cataract surgery, sequential recruitment, potential to see 20/40 (6/12) unaided or better postoperatively, no significant macular pathology and willing to follow up at 3 months.

Exclusion criteria

* Any ocular co-morbidity, which will preclude an expected postoperative 20/40 (6/12) unaided, distance vision. (e.g. amblyopia, corneal pathology, age related macular degeneration, glaucoma, diabetic retinopathy, other previous ocular surgeries), posterior capsule opacification,inability to read English text or physically or mentally unable to and cooperate with the postoperative assessment

Design outcomes

Primary

MeasureTime frameDescription
Uncorrected distance and near vision3 months postoperativelyUncorrected distance of 20/40 and near of J4

Secondary

MeasureTime frameDescription
Spherical error3 months postoperativelySpherical error on manifest refraction
astigmatic error3 months postoperativelyastigmatic error on manifest refraction
Pupil size3 months postoperativelyPupil size in mesopic condition
Total spherical and vertical coma aberrations3 months postoperativelyTotal spherical and vertical coma aberrations on aberrometry
Reading speed and critical font size3 months postoperativelyMeasured on Salzburg's reading desk

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026